Usual care mailing intervention
Otherroutine colposcopy reminder letter
NCT Number: NCT00873288
RATIONALE: Receiving a reminder letter from their doctor with questions to ask the Cancer Information Service may be more effective than a standard reminder letter in helping patients who have had an abnormal Pap test keep their follow-up colposcopy appointment.
PURPOSE: This randomized clinical trial is studying a personalized letter with Cancer Information Service support to see how well it works compared with a standard reminder letter in women scheduled for colposcopy after an abnormal Pap test.
Looking for future studies?
Notify Me18 year–100 year
Female
Interventional
Not applicable
Erie Family Health Center, Chicago, Illinois, United States
OBJECTIVES:
OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 intervention arms.
At their follow-up appointments, all patients undergo an exit interview to compare patient satisfaction between the 2 interventions. Patients in arm II also answer questions about their CIS experience, and if the intervention made their follow-up visit less difficult.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Exclusion criteria
routine colposcopy reminder letter
Mailed reminder plus provider recommendation to call CIS and sample questions to ask
Time frame: within 6 months of PAP
Patient satisfaction with provider-patient communication was assessed via administration of the Consumer Assessment of Health Plans Study (CAHPS) satisfaction questionnaire which rates satisfaction on a 1 to 3 scale. Scores are added together, with minimum score being 4 and the maximum score being 12, with a higher score indicating greater satisfaction.
Time frame: within 6 months of PAP
Time frame: within 6 months of PAP
Time frame: within 6 months of PAP
Time frame: WITHIN 6 MONTHS OF PAP
Northwestern University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00703196
Atypical Squamous Cells of the Cervix, Cervical Cancer
Birmingham, Alabama, United States
View Trial DetailsNCT00513526
Atypical Squamous Cells of the Cervix, Female Urogenital Diseases
Los Angeles, California, United States
View Trial DetailsNCT00653146
Atypical Squamous Cells of the Cervix, Cervical Cancer
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00458562
Atypical Squamous Cells of the Cervix, Cervical Cancer
Dakar, Senegal
View Trial Details